Cargando…
Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)
BACKGROUND: Due to the blood-brain barrier, plasma is not an ideal source to evaluate the genetic characteristics of central nervous system tumors. Thus, cerebrospinal fluid (CSF) is becoming an alternative biopsy type to evaluate the genetic landscape of intracranial tumors. We aimed to explore the...
Autores principales: | Li, Meichen, Chen, Jing, Zhang, Baishen, Yu, Juan, Wang, Na, Li, Delan, Shao, Yang, Zhu, Dongqin, Liang, Chuqiao, Ma, Yutong, Ou, Qiuxiang, Hou, Xue, Chen, Likun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661744/ https://www.ncbi.nlm.nih.gov/pubmed/36372873 http://dx.doi.org/10.1186/s12916-022-02595-8 |
Ejemplares similares
-
Correction: Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)
por: Li, Meichen, et al.
Publicado: (2023) -
Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)
por: Li, Meichen, et al.
Publicado: (2022) -
Primary intracranial Parachordoma: An unusual tumor in brain
por: Ghanta, Rajesh K., et al.
Publicado: (2014) -
Analysis of the Factors Related to Intracranial Infection after Brain Tumor Surgery
por: Chen, Weiying, et al.
Publicado: (2022) -
Intracranial stimulation for brain cancer—The case for implantable, intracranial tumor treating fields
por: Segar, David J, et al.
Publicado: (2023)